Ophthalmology Search
Ophthalmology Ophthalmology
blepharitis
BLEPHARITIS
Blepharitis is an inflammation process affecting the eyelid margins, eyelash follicles or openings of the anteriorly-placed accessory lacrimal glands and the posteriorly-placed Meibomian glands that causes ocular irritation and redness acutely but usually chronically.
It may have periods of exacerbations and remissions.
It usually occurs in middle-aged adults but can also start in childhood.
Can affect vision by disrupting the surface of the cornea and the bulbar conjunctiva; may influence tear film composition.

Follow Up

  • Follow-up visits are based on the severity of symptoms & signs, current treatment & comorbid factors
  • Includes interval history, visual acuity measurement, external exam, slit-lamp biomicroscopy, & intraocular pressure (IOP) measurement
  • Patients should be re-evaluated w/in a few weeks to determine the response to therapy & assess compliance to the treatment regimen
  • Prompt referral to an ophthalmologist is recommended if any of the following is observed
    • Visual loss
    • Moderate or severe pain
    • Severe or chronic redness
    • Involvement of the cornea
    • Recurrent episodes
    • Lack of response to treatment
Editor's Recommendations
Most Read Articles
Beta-blockers may reduce mortality in patients with heart failure, renal dysfunction
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.
New from USPSTF: Breast cancer risk-reduction recommendations
Elvira Manzano, Yesterday

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.
UTI risk not raised with SGLT-2is in real-world study
Pearl Toh, 2 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
Lower HbA1c prolongs hypoglycaemia duration in type 2 diabetics
5 days ago
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.